JPMORGAN CHASE & CO

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in KYTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$40,345

+$170 QoQ

Shares Held

4,675

+9.4% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. KYTX ranks #257 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$40,345	4,675	+9.4%	Shares	Defined	2026-05-13
2025-12-31	$40,175	4,274	-36.0%	Shares	Other	2026-02-11
2025-09-30	$40,050	6,675	-76.0%	Shares	Defined	2025-11-26
2025-06-30	$85,514	27,855	-29.5%	Shares	Defined	2025-08-12
2025-03-31	$76,238	39,502	-98.2%	Shares	Defined	2025-05-12
2024-12-31	$8,102,473	2,166,437	-9.3%	Shares	Defined	2025-02-12
2024-09-30	$11,674,147	2,387,352	+15.8%	Shares	Defined	2024-12-26
2024-06-30	$15,459,427	2,061,257	+144.1%	Shares	Defined	2024-12-26
2024-03-31	$20,976,510	844,465	—	Shares	Defined	2024-12-26
No filing history on record for this holder in this stock.